These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30534195)

  • 1. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.
    Kosako M; Akiho H; Miwa H; Kanazawa M; Fukudo S
    Biopsychosoc Med; 2018; 12():18. PubMed ID: 30534195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.
    Kanazawa M; Miwa H; Nakagawa A; Kosako M; Akiho H; Fukudo S
    Biopsychosoc Med; 2016; 10():19. PubMed ID: 27274765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey.
    Kosako M; Akiho H; Miwa H; Kanazawa M; Fukudo S
    Biopsychosoc Med; 2018; 12():12. PubMed ID: 30186363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.
    Ballou S; Rangan V; Eidelberg A; Proctor S; McHenry N; Nee J; Iturrino J; Lembo A; Singh P
    Am J Gastroenterol; 2023 Aug; 118(8):1402-1409. PubMed ID: 37053553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What impact do Rome IV criteria have on patients with IBS in China?
    Wang B; Zhao W; Zhao C; Jin H; Zhang L; Chen Q; Wang B
    Scand J Gastroenterol; 2019 Dec; 54(12):1433-1440. PubMed ID: 31829752
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria.
    Miwa H
    Patient Prefer Adherence; 2008 Feb; 2():143-7. PubMed ID: 19920955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome.
    Goodoory VC; Khasawneh M; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2024 Sep; 22(9):1942-1943. PubMed ID: 38423348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional bowel disorders in Iranian population using Rome III criteria.
    Sorouri M; Pourhoseingholi MA; Vahedi M; Safaee A; Moghimi-Dehkordi B; Pourhoseingholi A; Habibi M; Zali MR
    Saudi J Gastroenterol; 2010; 16(3):154-60. PubMed ID: 20616409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.